P-171 A phase I trial of gemcitabine, carboplatin or gemcitabine, paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG study

P-578 A phase I trial of gemcitabine, carboplatin or gemcitabine paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG study

Lung Cancer ◽

10.1016/s0169-5002(05)81071-2 ◽

2005 ◽

Vol 49 ◽

pp. S270

Author(s):

S. Swann ◽

H. Choy ◽

C. Walter ◽

G. Whipple ◽

W. Demas ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

A phase I trial of gemcitabine, carboplatin or gemcitabine, paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG study

10.1200/jco.2005.23.16_suppl.7103 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7103-7103

Author(s):

H. Choy ◽

S. Swann ◽

C. Walter ◽

G. Whipple ◽

W. Demas ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

P2-162: Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non small cell lung cancer (“CRITICAL”)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283820.31992.2b ◽

2007 ◽

Vol 2 (8) ◽

pp. S633-S634 ◽

Cited By ~ 8

Author(s):

David Ball ◽

Bryan Burmeister ◽

Paul Mitchell ◽

Michael Boyer ◽

Michael Mac Manus ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

Phase I trial of gefitinib (ZD1839) in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non-small cell lung cancer

10.1200/jco.2004.22.14_suppl.7077 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7077-7077 ◽

Cited By ~ 12

Author(s):

D. Rischin ◽

B. Burmeister ◽

P. Mitchell ◽

M. Boyer ◽

M. Macmanus ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

Phase I trial of gefitinib (ZD1839) in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non-small cell lung cancer

10.1200/jco.2004.22.90140.7077 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7077-7077 ◽

Cited By ~ 1

Author(s):

D. Rischin ◽

B. Burmeister ◽

P. Mitchell ◽

M. Boyer ◽

M. Macmanus ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

A Phase I Trial of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG 0017 Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.07.076 ◽

2005 ◽

Vol 63 ◽

pp. S42-S43

Author(s):

H. Choy ◽

S. Swann ◽

W. Curran ◽

G. Whipple ◽

W. Demas ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy (CRT) for Patients with Locally Advanced Non–small-cell Lung Cancer (LANSCLC): A Phase I Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.266 ◽

2009 ◽

Vol 75 (3) ◽

pp. S110 ◽

Cited By ~ 1

Author(s):

J.H. Heinzerling ◽

R.S. Hughes ◽

R. Govindan ◽

J.D. Bradley ◽

J.D. Schiller ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Locally Advanced ◽

Small Cell ◽

A Phase I Trial of Outpatient Weekly Irinotecan/Carboplatin and Concurrent Radiation for Stage III Unresectable Non–Small-Cell Lung Cancer: A Vanderbilt-Ingram Cancer Center Affiliate Network Trial

Clinical Lung Cancer ◽

10.3816/clc.2000.n.014 ◽

2000 ◽

Vol 1 (4) ◽

pp. 310-311 ◽

Cited By ~ 6

Author(s):

A. Chakravarthy ◽

Hak Choy

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

Cancer Center ◽

Phase I trial of neoadjuvant and postoperative paclitaxel (P), carboplatin (C) and erlotinib with concurrent accelerated hyperfractionation radiation (AHFR) followed by erlotinib maintenance therapy in stage III non-small cell lung cancer (NSCLC)

10.1200/jco.2005.23.16_suppl.2091 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 2091-2091

Author(s):

T. Mekhail ◽

T. Rice ◽

S. Murthy ◽

D. Adelstein ◽

G. Videtic ◽

...

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI)

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1871-5 ◽

2012 ◽

Vol 69 (6) ◽

pp. 1625-1631 ◽

Cited By ~ 5

Author(s):

Naoya Hida ◽

Hiroaki Okamoto ◽

Yuuki Misumi ◽

Akira Sato ◽

Mari Ishii ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Concurrent Chemoradiotherapy ◽

Small Cell ◽

Stage Iii ◽